Modulation of neutrophil extracellular traps release by Klebsiella pneumoniae

Federico Birnberg-Weiss1, Luis A Castillo1, Jose R Pittaluga1

  • 1Laboratorio de Fisiología de los Procesos Inflamatorios, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina, CABA, Argentina.

Insights

Klebsiella pneumoniae (KPC) evades immune defenses by inhibiting neutrophil extracellular traps (NETs) formation. This carbapenem-resistant pathogen prevents PMN bactericidal activity, impacting infection treatment.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Neutrophil extracellular traps (NETs) are crucial for combating bacterial infections.
  • Klebsiella pneumoniae carbapenemase (KPC) ST258 is a hyper-virulent pathogen associated with high mortality.
  • Understanding KPC's interaction with the host immune system is vital for effective treatment strategies.

Purpose of the Study:

  • To investigate the interaction between KPC ST258 and polymorphonuclear neutrophils (PMN).
  • To determine if KPC ST258 can modulate PMN bactericidal responses, specifically NETs formation.
  • To compare KPC ST258's effect on NETosis with that of Escherichia coli (Eco).

Main Methods:

  • Challenging PMN with KPC ST258 and Eco to assess NETs release.
  • Evaluating KPC ST258's ability to inhibit Eco-induced NETosis.
  • Investigating the role of hydrogen peroxide, soluble factors, cell wall components, and bacterial viability in KPC's inhibition of NETosis.
  • Analyzing PMN degranulation, focusing on primary granule mobilization.

Main Results:

  • KPC ST258 significantly inhibited NETs formation, unlike Eco.
  • KPC ST258 actively suppressed Eco-induced NETosis.
  • The inhibition of NETosis by KPC was independent of soluble factors or cell wall components and required bacterial viability.
  • KPC ST258 specifically impaired the mobilization of PMN primary granules, essential for bactericidal activity and NETosis.

Conclusions:

  • KPC ST258 possesses a mechanism to evade the PMN bactericidal response by inhibiting NETs release.
  • The evasion strategy involves the suppression of primary granule mobilization, crucial for effective pathogen clearance.
  • These findings highlight a novel immune evasion tactic by KPC ST258, informing potential therapeutic interventions.